Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nervous System Heredodegenerative Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05750693
What this trial is testing

PIK3CA in HER2+ BC and pCR Trial

Who this might be right for
HER2-positive Breast Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 58
Testing effectiveness (Phase 2)Study completedNCT01502046
What this trial is testing

Neuroprotection by Cannabinoids in Huntington's Disease

Who this might be right for
Huntington's Disease
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 25
Large-scale testing (Phase 3)Study completedNCT02471339
What this trial is testing

Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain

Who this might be right for
Neurofibromatosis Type 1Plexiform Neurofibromas
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Study completedNCT04114539
What this trial is testing

Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension

Who this might be right for
Tourette Syndrome in ChildrenTourette Syndrome in Adolescence
Emalex Biosciences Inc. 124
Testing effectiveness (Phase 2)Study completedNCT01965327
What this trial is testing

Interferon Gamma-1b in Friedreich Ataxia (FRDA)

Who this might be right for
Friedreich Ataxia
Children's Hospital of Philadelphia 12
Testing effectiveness (Phase 2)Study completedNCT02595983
What this trial is testing

The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant

Who this might be right for
Transthyretin (TTR)-Mediated AmyloidosisFamilial Amyloidotic Polyneuropathy (FAP)ATTR Amyloidosis+1 more
Alnylam Pharmaceuticals 12
Testing effectiveness (Phase 2)Study completedNCT02147886
What this trial is testing

Study To Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta in Patients With Machado-Joseph Disease

Who this might be right for
Machado-Joseph Disease / Spinocerebellar Ataxia 3
Bioblast Pharma Ltd. 15
Not applicableLooking for participantsNCT07154394
What this trial is testing

Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease

Who this might be right for
Dementia, Alzheimer TypeMild Cognitive ImpairmentCardiac Amyloidosis
University Hospital, Essen 15
Not applicableUnknownNCT04370470
What this trial is testing

Development of Assessments for Later Stage HD

Who this might be right for
Huntington Disease
CHDI Foundation, Inc. 340
Not applicableStudy completedNCT03709173
What this trial is testing

FuRST 2.0 Cognitive Pre-testing - Round 2

Who this might be right for
Huntington Disease
CHDI Foundation, Inc. 52
Not applicableLooking for participantsNCT03475173
What this trial is testing

New Non-invasive Modalities for Assessing Retinal Structure and Function

Who this might be right for
Ischemic Optic NeuropathyBranch Retinal Artery OcclusionHemianopia+2 more
Randy Kardon 500
Early research (Phase 1)UnknownNCT00675077
What this trial is testing

Far Infrared Irradiation for Managing, Control and Treatment of Huntington's Disease (HD)

Who this might be right for
Huntington Disease
GAAD Medical Research Institute Inc. 5
Early research (Phase 1)UnknownNCT04432857
What this trial is testing

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

Who this might be right for
Triple-negative Breast CancerNSCLC, Squamous or Non-SquamousUrothelial Carcinoma of the Bladder+2 more
Adlai Nortye Biopharma Co., Ltd. 63
Large-scale testing (Phase 3)Study completedNCT04298372
What this trial is testing

Frontline Lenalidomide for AL Amyloidosis Involving Myocardium

Who this might be right for
Amyloidosis Cardiac
Seoul National University Hospital 2
Testing effectiveness (Phase 2)Study completedNCT07010575
What this trial is testing

Patient Preference Study: Standard of Care Versus Once-daily Trientine Tetrahydrochloride

Who this might be right for
Wilson's Disease
Orphalan 10
Not applicableEnded earlyNCT03056144
What this trial is testing

Whole Body Vibration Therapy in Children With Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy Type 3
The Hong Kong Polytechnic University 1
Testing effectiveness (Phase 2)Study completedNCT02934256
What this trial is testing

Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

Who this might be right for
Vestibular SchwannomaNeurofibromatosis Type 2
Li Peng 10
Not applicableUnknownNCT04698551
What this trial is testing

NIPD on cffDNA for Triplet Repeat Diseases

Who this might be right for
Myotonic Dystrophy 1Huntington DiseaseFragile X Syndrome
University Hospital, Montpellier 36
Large-scale testing (Phase 3)Looking for participantsNCT06672237
What this trial is testing

NTLA-2001 in ATTRv-PN

Who this might be right for
Neuromuscular DiseaseNeuromuscular Diseases (NMD)Neurodegenerative Disease+17 more
Intellia Therapeutics 60
Not applicableLooking for participantsNCT07362875
What this trial is testing

Development of Quantitative Muscle Imaging as a Biomarker of Disease Endpoints in Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy
Wake Forest University Health Sciences 75
Next Page